NCT05598372

Brief Summary

This research was planned to determine the effect of two different methods on infant pain during vaccination and mother anxiety.The study was planned as a randomized controlled trial. The universe of this research consists of parents and their babies who come to Hocabey Family Health Center in Erzincan Center to receive the hepatitis B dose between these dates according to the vaccination calendar. In this study, it is planned to apply shotblocker and lullaby.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
90

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Oct 2022

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 25, 2022

Completed
Same day until next milestone

Study Start

First participant enrolled

October 25, 2022

Completed
3 days until next milestone

First Posted

Study publicly available on registry

October 28, 2022

Completed
1.1 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 13, 2023

Completed
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

December 22, 2024

Completed
Last Updated

March 17, 2025

Status Verified

June 1, 2024

Enrollment Period

1.1 years

First QC Date

October 25, 2022

Last Update Submit

March 13, 2025

Conditions

Outcome Measures

Primary Outcomes (2)

  • Newborn Infant Pain Scale (NIPS)

    The scale used in the assessment of newborn pain consists of 6 categories. It was developed in 1993 and its validity and reliability in our country was made in 1999. The score obtained from the scale varies between 0-7. Scale ; It consists of five behavioral indicators including facial expression, arm movement, leg movement, crying, alertness, and a physiological indicator that includes breathing.

    9 MONTHS

  • State Anxiety Inventory

    The State Anxiety Scale was developed in 1970, and its Turkish validity and reliability study in our country was conducted in 1994. There are a total of 40 statements in the scale. The first twenty items measure the level of anxiety related to the situation, and each statement is "Not at all" (1), "Somewhat" (2), "Very"(3), "Totally"(4). Reverse coded items; Items 1, 2, 5, 8, 10, 11, 15, 16, 19, 20. Points are added and subtracted according to the reverse and direct coded items in the scale. She states that 0-19 points obtained from the scale mean no anxiety, 20-39 points mean mild, 40-59 points mean moderate, 60-79 points mean severe anxiety, and individuals with a score of 60 and above need professional help.

    9 MONTHS

Study Arms (3)

shotblocker

EXPERIMENTAL

infant pain during vaccination and mother anxiety

Behavioral: shotblocker

lullaby

EXPERIMENTAL

infant pain during vaccination and mother anxiety

Behavioral: lullaby

CONTROL

NO INTERVENTION

not infant pain during vaccination and mother anxiety

Interventions

shotblockerBEHAVIORAL

infant pain during vaccination and mother anxiety

shotblocker
lullabyBEHAVIORAL

infant pain during vaccination and mother anxiety

lullaby

Eligibility Criteria

Age1 Month - 6 Months
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • The child does not have a disorder in the cognitive developmental area.
  • It is time to apply the hepatitis B vaccine of the 6th month.
  • Parent giving consent to participate in the study voluntarily and for their child to participate.

You may not qualify if:

  • The child has a disorder in the cognitive developmental area.
  • Failure to apply the 6th month hepatitis B vaccine.
  • Parent's voluntarily participating in the study and not giving consent for the child's participation.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ataturk University Nursing of Faculty

Erzurum, Center, 25240, Turkey (Türkiye)

Location

Study Officials

  • ARZU SARIALİOĞLU, PHD

    Ataturk University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
INVESTIGATOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

October 25, 2022

First Posted

October 28, 2022

Study Start

October 25, 2022

Primary Completion

December 13, 2023

Study Completion

December 22, 2024

Last Updated

March 17, 2025

Record last verified: 2024-06

Data Sharing

IPD Sharing
Will not share

THE ARTICLE IS INTENDED TO BE SHARED AFTER IT IS PUBLISHED

Locations